title: Postchemotherapy retroperitoneal lymph node dissection for testis cancer.
abstract: The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.
authors.affiliation: Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA. mcrisk@iupui.edu
authors.forename: Michael C
authors.initials: MC
authors.lastname: Risk
authors.forename: Richard S
authors.initials: RS
authors.lastname: Foster
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D012187:Retroperitoneal Space / Q000473:pathology / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D016896:Treatment Outcome